More than nine million people may miss out on cholesterol-lowering drugs that prevent heart attacks and strokes if doctors choose one set of medical guidelines over another, according to a new study.
That's because the government-backed U.S. Preventive Services Task Force (USPSTF) set a higher threshold for use of the drugs, known as statins, than the American College of Cardiology and the American Heart Association (ACC/AHA).
